G9556 – Final reports for ct, cta, mri or mra of the chest or neck with follow-up imaging not recommended

Long description

Final reports for ct, cta, mri or mra of the chest or neck with follow-up imaging not recommended

Short description

Ct/cta/mri/a no follup imag

Pricing indicator

00 Not separately priced by Part B (bundled, not covered or Part A only)

Medicare coverage

C Carrier judgment – coverage decided by the Medicare contractor

BETOS category

Z2 Undefined codes

Added

January 1, 2016

Last change

January 1, 2022 – No change

Nearby G codes

• G9548 – Final reports for imaging studies stating no follow-up imaging is recommended
• G9549 – Documentation of medical reason(s) that follow-up imaging is indicated (e.g., patient has lymphadenopathy, signs of metastasis or an active diagnosis or history of cancer, and other medical reason(s))
• G9550 – Final reports for imaging studies with follow-up imaging recommended, or final reports that do not include a specific recommendation of no follow-up
• G9551 – Final reports for imaging studies without an incidentally found lesion noted
• G9552 – Incidental thyroid nodule < 1.0 cm noted in report
• G9553 – Prior thyroid disease diagnosis
• G9554 – Final reports for ct, cta, mri or mra of the chest or neck with follow-up imaging recommended
• G9555 – Documentation of medical reason(s) for recommending follow up imaging (e.g., patient has multiple endocrine neoplasia, patient has cervical lymphadenopathy, other medical reason(s))
• G9557 – Final reports for ct, cta, mri or mra studies of the chest or neck without an incidentally found thyroid nodule < 1.0 cm noted or no nodule found
• G9558 – Patient treated with a beta-lactam antibiotic as definitive therapy
• G9559 – Documentation of medical reason(s) for not prescribing a beta-lactam antibiotic (e.g., allergy, intolerance to beta-lactam antibiotics)
• G9560 – Patient not treated with a beta-lactam antibiotic as definitive therapy, reason not given
• G9561 – Patients prescribed opiates for longer than six weeks
• G9562 – Patients who had a follow-up evaluation conducted at least every three months during opioid therapy
• G9563 – Patients who did not have a follow-up evaluation conducted at least every three months during opioid therapy
• G9572 – Index date phq-score greater than 9 documented during the twelve month denominator identification period